Creative Diagnostics, a US-based supplier of antibodies, antigens, and assay kits, has launched the Norovirus VP1 VLP Panel for research use.
This new panel supports NoV research with 14 VP1 Virus-Like Particles (VLPs) from various genogroups and genotypes. It includes GI.1, GI.5, GI.6, GI.7, GI.8, GII.1, GII.2, GII.3, GII.4, GII.6, GII.7, GII.12, GII.13, and GII.17.
It enables researchers to develop diagnostics, formulate vaccines, and expand studies on norovirus. The panel also allows researchers to examine a broader spectrum of norovirus diversity.
Each protein in the panel is provided in 50 μg quantities, with serotype-specific VP1 proteins also available for individual purchase in 0.5 mg vials.
Creative Diagnostics’ NoV recombinant proteins are produced using a baculovirus expression system, ensuring they closely resemble natural proteins. No additional foreign sequences are introduced, preserving product authenticity.
The proteins are purified using cesium chloride density gradient centrifugation, ensuring high purity. Transmission electron microscopy confirms the proteins’ morphology, enhancing activity and specificity.
Creative Diagnostics stated that the Norovirus VP1 VLP Panel is a key addition to its growing portfolio for infectious disease research.
This panel offers researchers a powerful tool to enhance their understanding of norovirus, facilitating advancements in vaccine development, antibody detection, and diagnostic assay creation.
In addition, the diagnostic products and services provider has introduced comprehensive Vaccine Development CRO Services to support the development of new vaccines for infectious diseases.
Creative Diagnostics also provides contract research and development (R&D), biologic manufacturing services for diagnostic manufacturers, and Good Manufacturing Practice (GMP) biologics manufacturing for the biopharmaceutical market.
The company aims to meet the assay development and manufacturing needs of researchers.
In January, Creative Diagnostics launched its new fluorescence-based PCR Insect Nucleic Acid Residue Assay Kits. These kits offer highly sensitive and specific detection of insect DNA residues, ensuring the quality and safety of biopharmaceuticals, research products, and other biological materials.
During the same month, the company introduced a new range of BNP and NT-proBNP antibodies for raw material production and research applications.
